External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort studyMauro Borzio, Fabio Fornari, E. Dionigi et al.|Hepatology|2017Cited by 49
Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathiesMichela Ileen Biondo, Raffaele D’Amelio, Valentina Germano et al.|European Journal of Internal Medicine|2014Cited by 34
Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in‐field multicenter cohort studyMauro Borzio, Rodolfo Sacco, Massimo Marignani et al.|Liver International|2017Cited by 23
Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in ItalyMarco Canzoni, Tommaso Stroffolini, Massimo Marignani et al.|Microorganisms|2020Cited by 13
Trend of Improving Prognosis of Hepatocellular Carcinoma in Clinical Practice: An Italian In-Field ExperienceMauro Borzio, Rodolfo Sacco, E. Dionigi et al.|Digestive Diseases and Sciences|2014Cited by 11